Richard Tella

Title: Innovator Richard Tella: Pioneering Pharmaceutical Analysis in Sunnyvale, CA

Introduction

Richard Tella is an inventive mind hailing from Sunnyvale, California. He has made significant contributions to the field of pharmaceutical analysis, holding a notable patent that enhances the evaluation of pharmaceutical dosage forms.

Latest Patents

Richard Tella's innovation, titled "Raman Analysis of Pharmaceutical Dosage Forms," focuses on advanced methods and apparatuses for the automatic analysis of pharmaceutical dosage forms. This patent describes a sophisticated system where a dosage form is gripped and positioned to receive light from both delivery and collection optics in various alignments. The light scattered through the dosage form is then collected and used for Raman spectral analysis, providing precise evaluations of the pharmaceutical products. Additionally, aspects of the invention include a rotation stage that helps achieve optimal alignment before the dosage form is subjected to optical analysis.

Career Highlights

Richard Tella is currently associated with Agilent Technologies, a prominent company known for its contributions to technology and analytical instrumentation. Within this innovative environment, he has worked diligently to develop and refine analytical techniques that support the pharmaceutical industry.

Collaborations

In his endeavors, Richard collaborates with his coworker, Craig Peters. Together, they contribute to technological advancements and foster an atmosphere of creativity and discovery within their field.

Conclusion

Richard Tella's work exemplifies the spirit of innovation that drives progress in pharmaceutical analysis. His patent represents a significant step forward in the automatic assessment of pharmaceutical dosage forms, showcasing his ability to blend technology with analytical rigor. As the industry continues to evolve, inventors like Tella play a crucial role in shaping the future of pharmaceutical sciences.